A clinical appraisal of pancuronium bromide and a comparative study of its cardiovascular effect.
نویسندگان
چکیده
منابع مشابه
Clinical Evaluation of Pipecuronium Bromide and its Comparison with Pancuronium Bromide
The study was carried out to compare the intubating conditions, cardiovascular responses, neuro-muscular blocking properties and reversal characteristics of pipecuronium bromide and pancuronium bromide. This is a prospective hospital based study. 100 patients belonging to ASA grade I or II physical status aged 18 to 70 years were divided into two groups of 50 patients each. Group 1 received pip...
متن کاملComparative potency of pipecuronium bromide and pancuronium bromide.
Cumulative dose-response curves were constructed to determine the comparative potency of pipecuronium and pancuronium. From these, the ED50 and ED95 values were calculated. These were 24.96 micrograms kg-1 and 44.96 micrograms kg-1, respectively, for pipecuronium and 30.42 micrograms kg-1 and 61.12 micrograms kg-1, respectively, for pancuronium.
متن کاملNeuromuscular and cardiovascular effects of pipecuronium.
Pipecuronium bromide (Arduan) is a bisquaternary, steroid-type neuromuscular blocking agent in clinical use in Eastern Europe. Before its introduction into clinical practice in the USA, in the first phase of this study the neuromuscular potency of pipecuronium was determined under "balanced" and enflurance anaesthesia by the cumulative log dose-response method in 30 patients each. In the second...
متن کاملPancuronium bromide induced joint contractures in the newborn.
We report three infants paralysed with pancuronium bromide as an adjunct to mechanical ventilation, who developed multiple joint contractures. In two term infants, gentamicin and phenobarbitone given together with pancuronium may have potentiated its effect, and in one preterm infant contractures, which became more severe after paralysis, were present at birth.
متن کاملEffects of general anaesthesia on the intraocular pressure in man. Comparison of tubocurarine and pancuronium in nitrous oxide and oxygen.
The introduction of new anaesthetic drugs demands that their action should be compared with that of already established agents. Pancuronium bromide was introduced into clinical anaesthetic practice by Baird and Reid (I967), and has since achieved widespread acceptance because it is reputed to have fewer cardiovascular side-effects than other non-depolarizing relaxants (Baird, I968; Sellick, 197...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- AANA journal
دوره 43 3 شماره
صفحات -
تاریخ انتشار 1975